About this Journal Submit a Manuscript Table of Contents
Advances in Virology
Volume 2011 (2011), Article ID 403419, 14 pages
http://dx.doi.org/10.1155/2011/403419
Review Article

Murine Leukemia Viruses: Objects and Organisms

HIV Drug Resistance Program, National Cancer Institute-Frederick, Frederick, MD 21702, USA

Received 3 June 2011; Accepted 25 July 2011

Academic Editor: Arifa S. Khan

Copyright © 2011 Alan Rein. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. L. Linial, et al., “Retroviridae. Virus taxonomy: classification and nomenclature of viruses,” in Proceedings of the International Committee on Taxonomy of Viruses, C. M. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger, and L. A. Ball, Eds., pp. 421–440, Elsevier/Academic Press, San Diego, Calif, USA, 2004.
  2. L. Gross, ““Spontaneous” leukemia developing in C3H mice following inoculation in infancy, with AK-leukemic extracts, or AK-embrvos,” Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine, vol. 76, no. 1, pp. 27–32, 1951. View at Scopus
  3. L. Gross, “Development and serial cellfree passage of a highly potent strain of mouse leukemia virus,” Proceedings of the Society for Experimental Biology and Medicine, vol. 94, pp. 767–771, 1957.
  4. J. B. Moloney, “Biological studies on a lymphoid-leukemia virus extracted from sarcoma 37. I. Origin and introductory investigations,” Journal of the National Cancer Institute, vol. 24, pp. 933–951, 1960. View at Scopus
  5. P. F. Lewis and M. Emerman, “Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus,” Journal of Virology, vol. 68, no. 1, pp. 510–516, 1994. View at Scopus
  6. T. Roe, T. C. Reynolds, G. Yu, and P. O. Brown, “Integration of murine leukemia virus DNA depends on mitosis,” EMBO Journal, vol. 12, no. 5, pp. 2099–2108, 1993. View at Scopus
  7. L. Jarrosson-Wuilleme, C. Goujon, J. Bernaud, D. Rigal, J. L. Darlix, and A. Cimarelli, “Transduction of nondividing human macrophages with gammaretrovirus-derived vectors,” Journal of Virology, vol. 80, no. 3, pp. 1152–1159, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. X. H. Liu, W. Xu, J. Russ, L. E. Eiden, and M. V. Eiden, “The host range of gammaretroviruses and gammaretroviral vectors includes post-mitotic neural cells,” PLoS ONE, vol. 6, no. 3, Article ID e18072, 2011. View at Publisher · View at Google Scholar · View at PubMed
  9. M. Yeager, E. M. Wilson-Kubalek, S. G. Weiner, P. O. Brown, and A. Rein, “Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 13, pp. 7299–7304, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. D. E. Ott, “Cellular proteins detected in HIV-1,” Reviews in Medical Virology, vol. 18, no. 3, pp. 159–175, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. J. E. Bubbers and F. Lilly, “Selective incorporation of H 2 antigenic determinants into Friend virus particles,” Nature, vol. 266, no. 5601, pp. 458–459, 1977. View at Scopus
  12. L. M. Albritton, L. Tseng, D. Scadden, and J. M. Cunningham, “A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection,” Cell, vol. 57, no. 4, pp. 659–666, 1989.
  13. J. L. Battini, J. E. J. Rasko, and A. D. Miller, “A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 4, pp. 1385–1390, 1999. View at Publisher · View at Google Scholar
  14. C. S. Tailor, A. Nouri, C. G. Lee, C. Kozak, and D. Kabat, “Cloning and characterization of a cell surface receptor for xenotropic and polytropic marine leukemia viruses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 3, pp. 927–932, 1999.
  15. Y. L. Yang, L. Guo, S. Xu et al., “Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1,” Nature Genetics, vol. 21, no. 2, pp. 216–219, 1999. View at Publisher · View at Google Scholar · View at PubMed
  16. D. G. Miller and A. D. Miller, “A family of retroviruses that utilize related phosphate transporters for cell entry,” Journal of Virology, vol. 68, no. 12, pp. 8270–8276, 1994.
  17. C. A. Wilson, K. B. Farrell, and M. V. Eiden, “Properties of a unique form of the murine amphotropic leukemia virus receptor expressed on hamster cells,” Journal of Virology, vol. 68, no. 12, pp. 7697–7703, 1994.
  18. T. M. Shinnick, R. A. Lerner, and J. G. Sutcliffe, “Nucleotide sequence of Moloney murine leukaemia virus,” Nature, vol. 293, no. 5833, pp. 543–548, 1981.
  19. C. S. Badorrek and K. M. Weeks, “RNA flexibility in the dimerization domain of a gamma retrovirus,” Nature Chemical Biology, vol. 1, no. 2, pp. 104–111, 2005. View at Publisher · View at Google Scholar · View at PubMed
  20. C. Gherghe, T. Lombo, C. W. Leonard et al., “Definition of a high-affinity Gag recognition structure mediating packaging of a retroviral RNA genome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 45, pp. 19248–19253, 2010. View at Publisher · View at Google Scholar · View at PubMed
  21. A. Rein, S. A. Datta, C. P. Jones, and K. Musier-Forsyth, “Diverse interactions of retroviral Gag proteins with RNAs,” Trends in Biochemical Sciences, vol. 36, no. 7, pp. 373–380, 2011.
  22. H. Yang, J. Wang, X. Jia et al., “Structural insight into the mechanisms of enveloped virus tethering by tetherin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 43, pp. 18428–18432, 2010. View at Publisher · View at Google Scholar · View at PubMed
  23. O. Pornillos, J. E. Garrus, and W. I. Sundquist, “Mechanisms of enveloped RNA virus budding,” Trends in Cell Biology, vol. 12, no. 12, pp. 569–579, 2002. View at Publisher · View at Google Scholar
  24. K. M. Felsenstein and S. P. Goff, “Expression of the gag-pol fusion protein of Moloney murine leukemia virus without gag protein does not induce virion formation or proteolytic processing,” Journal of Virology, vol. 62, no. 6, pp. 2179–2182, 1988.
  25. Y. X. Feng, H. Yuan, A. Rein, and J. G. Levin, “Bipartite signal for read-through suppression in murine leukemia virus mRNA: an eight-nucleotide purine-rich sequence immediately downstream of the gag termination codon followed by an RNA pseudoknot,” Journal of Virology, vol. 66, no. 8, pp. 5127–5132, 1992.
  26. Y. Yoshinaka, I. Katoh, T. D. Copeland, and S. Oroszlan, “Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 6, pp. 1618–1622, 1985.
  27. Y. X. Feng, T. D. Copeland, S. Oroszlan, A. Rein, and J. G. Levin, “Identification of amino acids inserted during suppression of UAA and UGA termination codons at the gag-pol junction of Moloney murine leukemia virus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 22, pp. 8860–8863, 1990. View at Publisher · View at Google Scholar
  28. Y. X. Feng, J. G. Levin, D. L. Hatfield, T. S. Schaefer, R. J. Gorelick, and A. Rein, “Suppression of UAA and UGA termination codons in mutant murine leukemia viruses,” Journal of Virology, vol. 63, no. 6, pp. 2870–2873, 1989.
  29. T. Jacks, M. D. Power, F. R. Masiarz, P. A. Luciw, P. J. Barr, and H. E. Varmus, “Characterization of ribosomal frameshifting in HIV-1 gag-pol expression,” Nature, vol. 331, no. 6153, pp. 280–283, 1988.
  30. T. Jacks and H. E. Varmus, “Expression of the Rous sarcoma virus pol gene by ribosomal frameshifting,” Science, vol. 230, no. 4731, pp. 1237–1242, 1985.
  31. D. L. Hatfield, J. G. Levin, A. Rein, and S. Oroszlan, “Translational suppression in retroviral GENE expression,” Advances in Virus Research, vol. 41, pp. 193–239, 1992. View at Publisher · View at Google Scholar
  32. P. O. Brown, “Integration,” in Retroviruses, J. M. Coffin, S. H. Hughes, and H. E. Varmus, Eds., pp. 161–203, Cold Spring Harbor Laboratory Press, Plainview, NY, USA, 1997.
  33. J. Colicelli and S. P. Goff, “Mutants and pseudorevertants of Moloney murine leukemia virus with alterations at the integration site,” Cell, vol. 42, no. 2, pp. 573–580, 1985.
  34. J. Colicelli and S. P. Goff, “Sequence and spacing requirements of a retrovirus integration site,” Journal of Molecular Biology, vol. 199, no. 1, pp. 47–59, 1988.
  35. S. J. Rulli Jr., C. S. Hibbert, J. Mirro, T. Pederson, S. Biswal, and A. Rein, “Selective and nonselective packaging of cellular RNAs in retrovirus particles,” Journal of Virology, vol. 81, no. 12, pp. 6623–6631, 2007. View at Publisher · View at Google Scholar · View at PubMed
  36. V. D'Souza and M. F. Summers, “Structural basis for packaging the dimeric genome of Moloney murine leukaemia virus,” Nature, vol. 431, no. 7008, pp. 586–590, 2004. View at Publisher · View at Google Scholar · View at PubMed
  37. D. A. M. Konings, M. A. Nash, J. V. Maizel, and R. B. Arlinghaus, “Novel GACG-hairpin pair motif in the 5' untranslated region of type C retroviruses related to murine leukemia virus,” Journal of Virology, vol. 66, no. 2, pp. 632–640, 1992.
  38. C. Gherghe, C. W. Leonard, R. J. Gorelick, and K. M. Weeks, “Secondary structure of the mature ex virio Moloney murine leukemia virus genomic RNA dimerization domain,” Journal of Virology, vol. 84, no. 2, pp. 898–906, 2010. View at Publisher · View at Google Scholar · View at PubMed
  39. C. H. Kim and I Tinoco Jr., “A retroviral RNA kissing complex containing only two G·C base pairs,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 17, pp. 9396–9401, 2000.
  40. B. Levinson, G. Khoury, G. Vande Woude, and P. Gruss, “Activation of SV40 genome by 72-base pair tandem repeats of Moloney sarcoma virus,” Nature, vol. 295, no. 5850, pp. 568–572, 1982. View at Publisher · View at Google Scholar
  41. A. B. Rabson and B. J. Graves, “Synthesis and processing of viral RNA,” in Retroviruses, J. M. Coffin, S. H. Hughes, and H. E. Varmus, Eds., pp. 205–262, Cold Spring Harbor Laboratory Press, New York, NY, USA, 1997.
  42. L. E. Henderson, H. C. Krutzsch, and S. Oroszlan, “Myristyl amino-terminal acylation of murine retrovirus proteins: an unusual post-translational protein modification,” Proceedings of the National Academy of Sciences of the United States of America, vol. 80, no. 2, pp. 339–343, 1983.
  43. A. Rein, M. R. McClure, N. R. Rice, R. B. Luftig, and A. M. Schultz, “Myristylation site in Pr65(gag) is essential for virus particle formation by Moloney murine leukemia virus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 19, pp. 7246–7250, 1986.
  44. B. Yuan, S. Campbell, E. Bacharach, A. Rein, and S. P. Goff, “Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses,” Journal of Virology, vol. 74, no. 16, pp. 7250–7260, 2000. View at Publisher · View at Google Scholar
  45. C. Segura-Morales, C. Pescia, C. Chatellard-Causse, R. Sadoul, E. Bertrand, and E. Basyuk, “Tsg101 and Alix interact with murine leukemia virus Gag and cooperate with Nedd4 ubiquitin ligases during budding,” Journal of Biological Chemistry, vol. 280, no. 29, pp. 27004–27012, 2005. View at Publisher · View at Google Scholar · View at PubMed
  46. A. Prizan-Ravid, E. Elis, N. Laham-Karam, S. Selig, M. Ehrlich, and E. Bacharach, “The Gag cleavage product, p12, is a functional constituent of the murine leukemia virus pre-integration complex,” PLoS Pathogens, vol. 6, no. 11, Article ID e1001183, 2010. View at Publisher · View at Google Scholar · View at PubMed
  47. B. Yuan, A. Fassati, A. Yueh, and S. P. Goff, “Characterization of Moloney murine leukemia virus p12 mutants blocked during early events of infection,” Journal of Virology, vol. 76, no. 21, pp. 10801–10810, 2002. View at Publisher · View at Google Scholar
  48. A. Yueh and S. P. Goff, “Phosphorylated serine residues and an arginine-rich domain of the Moloney murine leukemia virus p12 protein are required for early events of viral infection,” Journal of Virology, vol. 77, no. 3, pp. 1820–1829, 2003. View at Publisher · View at Google Scholar
  49. M. R. Auerbach, C. Shu, A. Kaplan, and I. R. Singh, “Functional characterization of a portion of the Moloney murine leukemia virus gag gene by genetic footprinting,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 20, pp. 11678–11683, 2003. View at Publisher · View at Google Scholar · View at PubMed
  50. B. Yuan, X. Li, and S. P. Goff, “Mutations altering the Moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle,” EMBO Journal, vol. 18, no. 17, pp. 4700–4710, 1999. View at Publisher · View at Google Scholar · View at PubMed
  51. M. Oshima, D. Muriaux, J. Mirro et al., “Effects of blocking individual maturation cleavages in murine leukemia virus Gag,” Journal of Virology, vol. 78, no. 3, pp. 1411–1420, 2004. View at Publisher · View at Google Scholar
  52. S. K. Kyere, P. R. B. Joseph, and M. F. Summers, “The p12 domain is unstructured in a murine leukemia virus p12-CA(N) Gag construct,” PLoS ONE, vol. 3, no. 4, Article ID e1902, 2008. View at Publisher · View at Google Scholar · View at PubMed
  53. A. C. Prats, G. De Billy, P. Wang, and J. L. Darlix, “CUG initiation codon used for the synthesis of a cell surface antigen coded by the murine leukemia virus,” Journal of Molecular Biology, vol. 205, no. 2, pp. 363–372, 1989.
  54. R. Fujisawa, F. J. McAtee, C. Favara, S. F. Hayes, and J. L. Portis, “N-terminal cleavage fragment of glycosylated Gag is incorporated into murine oncornavirus particles,” Journal of Virology, vol. 75, no. 22, pp. 11239–11243, 2001. View at Publisher · View at Google Scholar · View at PubMed
  55. A. Corbin, A. C. Prats, J. L. Darlix, and M. Sitbon, “A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses,” Journal of Virology, vol. 68, no. 6, pp. 3857–3867, 1994.
  56. P. Schwartzberg, J. Colicelli, and S. P. Goff, “Deletion mutants of Moloney murine leukemia virus which lack glycosylated gag protein are replication competent,” Journal of Virology, vol. 46, no. 2, pp. 538–546, 1983.
  57. A. Low, S. Datta, Y. Kuznetsov et al., “Mutation in the glycosylated gag protein of murine leukemia virus results in reduced in vivo infectivity and a novel defect in viral budding or release,” Journal of Virology, vol. 81, no. 8, pp. 3685–3692, 2007. View at Publisher · View at Google Scholar · View at PubMed
  58. T. Nitta, R. Tam, J. W. Kim, and H. Fan, “The cellular protein La functions in enhancement of virus release through lipid rafts facilitated by murine leukemia virus glycosylated Gag,” mBio, vol. 2, no. 1, 2011. View at Publisher · View at Google Scholar · View at PubMed
  59. M. Pizzato, “MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 20, pp. 9364–9369, 2010. View at Publisher · View at Google Scholar · View at PubMed
  60. R. J. Gorelick, W. Fu, T. D. Gagliardi et al., “Characterization of the block in replication of nucleocapsid protein zinc finger mutants from Moloney murine leukemia virus,” Journal of Virology, vol. 73, no. 10, pp. 8185–8195, 1999.
  61. R. J. Gorelick, L. E. Henderson, J. P. Hanser, and A. Rein, “Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a “zinc finger-like” protein sequence,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 22, pp. 8420–8424, 1988.
  62. L. E. Henderson, R. Sowder, T. D. Copeland, G. Smythers, and S. Oroszlan, “Quantitative separation of murine leukemia virus proteins by reversed-phase high-pressure liquid chromatography reveals newly described gag and env cleavage products,” Journal of Virology, vol. 52, no. 2, pp. 492–500, 1984.
  63. L. Menendez-Arias, D. Gotte, and S. Oroszlan, “Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme,” Virology, vol. 196, no. 2, pp. 557–563, 1993. View at Publisher · View at Google Scholar · View at PubMed
  64. R. Swanstrom and J. W. Wills, “Synthesis, assembly, and processing of viral proteins,” in Retroviruses, J. M. Coffin, S. H. Hughes, and H. E. Varmus, Eds., pp. 263–334, Cold Spring Harbor Laboratory Press, Plainview, NY, USA, 1997.
  65. D. Das and M. M. Georgiadis, “The crystal structure of the monomeric reverse transcriptase from Moloney murine leukemia virus,” Structure, vol. 12, no. 5, pp. 819–829, 2004. View at Publisher · View at Google Scholar · View at PubMed
  66. K. Moelling, “Characterization of reverse transcriptase and RNase H from friend-murine leukemia virus,” Virology, vol. 62, no. 1, pp. 46–59, 1974.
  67. A. Telesnitsky and S. P. Goff, “Reverse transcriptase and the generation of retroviral DNA,” in Retroviruses, J. M. Coffin, S. H. Hughes, and H. E. Varmus, Eds., pp. 121–160, Cold Spring Harbor Laboratory Press, Plainview, NY, USA, 1997.
  68. S. Hare, F. Di Nunzio, A. Labeja, J. Wang, A. Engelman, and P. Cherepanov, “Structural basis for functional tetramerization of lentiviral integrase,” PLoS Pathogens, vol. 5, no. 7, Article ID e1000515, 2009. View at Publisher · View at Google Scholar · View at PubMed
  69. S. Hare, S. S. Gupta, E. Valkov, A. Engelman, and P. Cherepanov, “Retroviral intasome assembly and inhibition of DNA strand transfer,” Nature, vol. 464, no. 7286, pp. 232–236, 2010. View at Publisher · View at Google Scholar · View at PubMed
  70. A. Schultz and A. Rein, “Maturation of murine leukemia virus env proteins in the absence of other viral proteins,” Virology, vol. 145, no. 2, pp. 335–339, 1985.
  71. B. A. Brody, S. S. Rhee, and E. Hunter, “Postassembly cleavage of a retroviral glycoprotein cytoplasmic domain removes a necessary incorporation signal and activates fusion activity,” Journal of Virology, vol. 68, no. 7, pp. 4620–4627, 1994.
  72. M. A. Sommerfelt, S. R. Petteway Jr., G. B. Dreyer, and E. Hunter, “Effect of retroviral proteinase inhibitors on Mason-Pfizer monkey virus maturation and transmembrane glycoprotein cleavage,” Journal of Virology, vol. 66, no. 7, pp. 4220–4227, 1992.
  73. N. R. Rice, L. E. Henderson, R. C. Sowder, T. D. Copeland, S. Oroszlan, and J. F. Edwards, “Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus,” Journal of Virology, vol. 64, no. 8, pp. 3770–3778, 1990.
  74. E. Hunter, “Viral entry and receptors,” in Retroviruses, J. M. Coffin, S. H. Hughes, and H. E. Varmus, Eds., pp. 71–119, Cold Spring Harbor Laboratory Press, Plainview, NY, USA, 1997.
  75. D. Fass, R. A. Davey, C. A. Hamson, P. S. Kim, J. M. Cunningham, and J. M. Berger, “Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution,” Science, vol. 277, no. 5332, pp. 1662–1666, 1997. View at Publisher · View at Google Scholar
  76. D. Fass, S. C. Harrison, and P. S. Kim, “Retrovirus envelope domain at 1.7 Å resolution,” Nature Structural Biology, vol. 3, no. 5, pp. 465–469, 1996.
  77. B. Kobe, R. L. Center, B. E. Kemp, and P. Poumbourios, “Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 8, pp. 4319–4324, 1999. View at Publisher · View at Google Scholar
  78. A. Pinter, R. Kopelman, Z. Li, S. C. Kayman, and D. A. Sanders, “Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes,” Journal of Virology, vol. 71, no. 10, pp. 8073–8077, 1997.
  79. E. O. Freed and R. Risser, “The role of envelope glycoprotein processing in murine leukemia virus infection,” Journal of Virology, vol. 61, no. 9, pp. 2852–2856, 1987.
  80. J. A. Ragheb and W. F. Anderson, “pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry,” Journal of Virology, vol. 68, no. 5, pp. 3220–3231, 1994.
  81. A. Rein, J. Mirro, J. G. Haynes, S. M. Ernst, and K. Nagashima, “Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein,” Journal of Virology, vol. 68, no. 3, pp. 1773–1781, 1994.
  82. M. Li, Z. N. Li, Q. Yao, C. Yang, D. A. Steinhauer, and R. W. Compans, “Murine leukemia virus R peptide inhibits influenza virus hemagglutinin-induced membrane fusion,” Journal of Virology, vol. 80, no. 12, pp. 6106–6114, 2006. View at Publisher · View at Google Scholar · View at PubMed
  83. M. Wallin, M. Ekström, and H. Garoff, “Isomerization of the intersubunit disulphide-bond in Env controls retrovirus fusion,” EMBO Journal, vol. 23, no. 1, pp. 54–65, 2004. View at Publisher · View at Google Scholar · View at PubMed
  84. K. Li, S. Zhang, M. Kronqvist, M. Ekström, M. Wallin, and H. Garoff, “The conserved His8 of the Moloney murine leukemia virus Env SU subunit directs the activity of the SU-TM disulphide bond isomerase,” Virology, vol. 361, no. 1, pp. 149–160, 2007. View at Publisher · View at Google Scholar · View at PubMed
  85. A. L. Barnett and J. M. Cunningham, “Receptor binding transforms the surface subunit of the mammalian C-type retrovirus envelope protein from an inhibitor to an activator of fusion,” Journal of Virology, vol. 75, no. 19, pp. 9096–9105, 2001. View at Publisher · View at Google Scholar · View at PubMed
  86. A. L. Barnett, R. A. Davey, and J. M. Cunningham, “Modular organization of the Friend murine leukemia virus envelope protein underlies the mechanism of infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 7, pp. 4113–4118, 2001. View at Publisher · View at Google Scholar · View at PubMed
  87. D. Lavillette, A. Ruggieri, S. J. Russell, and F. L. Cosset, “Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments,” Journal of Virology, vol. 74, no. 1, pp. 295–304, 2000.
  88. S. K. Chattopadhyay, M. R. Lander, E. Rands, S. Gupta, and D. R. Lowy, “Origin of mink cytopathic focus-forming (MCF) viruses: comparison with ecotropic and xenotropic murine leukemia virus genomes,” Virology, vol. 113, no. 2, pp. 465–483, 1981.
  89. J. W. Hartley, N. K. Wolford, L. J. Old, and W. P. Rowe, “A new class of murine leukemia virus associated with development of spontaneous lymphomas,” Proceedings of the National Academy of Sciences of the United States of America, vol. 74, no. 2, pp. 789–792, 1977.
  90. R. A. Bosselman, F. van Straaten, C. van Beveren, I. M. Verma, and M. Vogt, “Analysis of the env gene of a molecularly cloned and biologically active Moloney mink cell focus-forming proviral DNA,” Journal of Virology, vol. 44, no. 1, pp. 19–31, 1982.
  91. A. Rein, “Interference grouping of murine leukemia viruses: a distinct receptor for the MCF-recombinant viruses in mouse cells,” Virology, vol. 120, no. 1, pp. 251–257, 1982.
  92. D. L. Wensel, W. Li, and J. M. Cunningham, “A virus-virus interaction circumvents the virus receptor requirement for infection by pathogenic retroviruses,” Journal of Virology, vol. 77, no. 6, pp. 3460–3469, 2003. View at Publisher · View at Google Scholar
  93. G. J. Cianciolo, T. D. Copeland, S. Oroszlan, and R. Snyderman, “Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins,” Science, vol. 230, no. 4724, pp. 453–455, 1985.
  94. G. Schlecht-Louf, M. Renard, M. Mangeney et al., “Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretroviruses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 8, pp. 3782–3787, 2010. View at Publisher · View at Google Scholar · View at PubMed
  95. A. Rein and A. Schultz, “Different recombinant murine leukemia viruses use different cell surface receptors,” Virology, vol. 136, no. 1, pp. 144–152, 1984.
  96. C. S. Tailor, D. Lavillette, M. Marin, and D. Kabat, “Cell surface receptors for gammaretroviruses,” Current Topics in Microbiology and Immunology, vol. 281, pp. 29–106, 2003.
  97. H. M. Temin and H. Rubin, “Characteristics of an assay for Rous sarcoma virus and Rous sarcoma cells in tissue culture,” Virology, vol. 6, no. 3, pp. 669–688, 1958.
  98. W. P. Rowe, W. E. Pugh, and J. W. Hartley, “Plaque assay techniques for murine leukemia viruses,” Virology, vol. 42, no. 4, pp. 1136–1139, 1970.
  99. R. H. Bassin, N. Tuttle, and P. J. Fischinger, “Rapid cell culture assay technique for murine leukaemia viruses,” Nature, vol. 229, no. 5286, pp. 564–566, 1971. View at Publisher · View at Google Scholar
  100. S. J. Rulli Jr., J. Mirro, S. A. Hill et al., “Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses,” Journal of Virology, vol. 82, no. 13, pp. 6566–6575, 2008. View at Publisher · View at Google Scholar · View at PubMed
  101. D. Mazurov, A. Ilinskaya, G. Heidecker, P. Lloyd, and D. Derse, “Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors,” PLoS Pathogens, vol. 6, no. 2, Article ID e1000788, 2010. View at Publisher · View at Google Scholar · View at PubMed
  102. R. H. Bassin, S. Ruscetti, I. Ali, D. K. Haapala, and A. Rein, “Normal DBA/2 mouse cells synthesize a glycoprotein which interferes with MCF virus infection,” Virology, vol. 123, no. 1, pp. 139–151, 1982.
  103. H. Ikeda and T. Odaka, “A cell membrane “gp70” associated with Fv-4 gene: immunological characterization and tissue and strain distribution,” Virology, vol. 133, no. 1, pp. 65–76, 1984.
  104. T. Pincus, W. P. Rowe, and F. Lilly, “A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to friend murine leukemia virus,” Journal of Experimental Medicine, vol. 133, no. 6, pp. 1234–1241, 1971.
  105. H. C. T. Groom, M. W. Yap, R. P. Galão, S. J. D. Neil, and K. N. Bishop, “Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 11, pp. 5166–5171, 2010. View at Publisher · View at Google Scholar · View at PubMed
  106. S. Best, P. L. Tissier, G. Towers, and J. P. Stoye, “Positional cloning of the mouse retrovirus restriction gene Fv1,” Nature, vol. 382, no. 6594, pp. 826–829, 1996. View at Publisher · View at Google Scholar · View at PubMed
  107. M. W. Yap and J. P. Stoye, “Intracellular localisation of Fv1,” Virology, vol. 307, no. 1, pp. 76–89, 2003. View at Publisher · View at Google Scholar
  108. G. Duran-Troise, R. H. Bassin, A. Rein, and B. I. Gerwin, “Loss of Fv 1 restriction in Balb/3T3 cells following infection with a single N tropic murine leukemia virus particle,” Cell, vol. 10, no. 3, pp. 479–488, 1977.
  109. R. H. Bassin, G. Duran-Troise, B. I. Gerwin, and A. Rein, “Abrogation of Fv-1(b) restriction with murine leukemia viruses inactivated by heat or by gamma irradiation,” Journal of Virology, vol. 26, no. 2, pp. 306–315, 1978.
  110. K. N. Bishop, G. B. Mortuza, S. Howell, M. W. Yap, J. P. Stoye, and I. A. Taylor, “Characterization of an amino-terminal dimerization domain from retroviral restriction factor Fv1,” Journal of Virology, vol. 80, no. 16, pp. 8225–8235, 2006. View at Publisher · View at Google Scholar · View at PubMed
  111. M. W. Yap, G. B. Mortuza, I. A. Taylor, and J. P. Stoye, “The design of artificial retroviral restriction factors,” Virology, vol. 365, no. 2, pp. 302–314, 2007. View at Publisher · View at Google Scholar · View at PubMed
  112. L. Hilditch, R. Matadeen, D. C. Goldstone, P. B. Rosenthal, I. A. Taylor, and J. P. Stoye, “Ordered assembly of murine leukemia virus capsid protein on lipid nanotubes directs specific binding by the restriction factor, Fv1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 14, pp. 5771–5776, 2011. View at Publisher · View at Google Scholar · View at PubMed
  113. G. Towers, M. Bock, S. Martin, Y. Takeuchi, J. P. Stoye, and O. Danos, “A conserved mechanism of retrovirus restriction in mammals,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 22, pp. 12295–12299, 2000. View at Publisher · View at Google Scholar · View at PubMed
  114. R. S. Harris and M. T. Liddament, “Retroviral restriction by APOBEC proteins,” Nature Reviews Immunology, vol. 4, no. 11, pp. 868–877, 2004. View at Publisher · View at Google Scholar · View at PubMed
  115. R. S. LaRue, V. Andrésdóttir, Y. Blanchard et al., “Guidelines for naming nonprimate APOBEC3 genes and proteins,” Journal of Virology, vol. 83, no. 2, pp. 494–497, 2009. View at Publisher · View at Google Scholar · View at PubMed
  116. A. Low, C. M. Okeoma, N. Lovsin et al., “Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene,” Virology, vol. 385, no. 2, pp. 455–463, 2009. View at Publisher · View at Google Scholar · View at PubMed
  117. C. M. Okeoma, N. Lovsin, B. M. Peterlin, and S. R. Ross, “APOBEC3 inhibits mouse mammary tumour virus replication in vivo,” Nature, vol. 445, no. 7130, pp. 927–930, 2007. View at Publisher · View at Google Scholar · View at PubMed
  118. R. K. Holmes, M. H. Malim, and K. N. Bishop, “APOBEC-mediated viral restriction: not simply editing?” Trends in Biochemical Sciences, vol. 32, no. 3, pp. 118–128, 2007. View at Publisher · View at Google Scholar · View at PubMed
  119. J. L. Mbisa, R. Barr, J. A. Thomas et al., “Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration,” Journal of Virology, vol. 81, no. 13, pp. 7099–7110, 2007. View at Publisher · View at Google Scholar · View at PubMed
  120. M. A. Langlois, K. Kemmerich, C. Rada, and M. S. Neuberger, “The AKV murine leukemia virus is restricted and hypermutated by mouse APOBEC3,” Journal of Virology, vol. 83, no. 22, pp. 11550–11559, 2009. View at Publisher · View at Google Scholar · View at PubMed
  121. T. Paprotka, N. J. Venkatachari, C. Chaipan et al., “Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs,” Journal of Virology, vol. 84, no. 11, pp. 5719–5729, 2010. View at Publisher · View at Google Scholar · View at PubMed
  122. K. Stieler and N. Fischer, “Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV,” PLoS ONE, vol. 5, no. 7, Article ID e11738, 2010. View at Publisher · View at Google Scholar · View at PubMed
  123. E. P. Browne and D. R. Littman, “Species-specific restriction of Apobec3-mediated hypermutation,” Journal of Virology, vol. 82, no. 3, pp. 1305–1313, 2008. View at Publisher · View at Google Scholar · View at PubMed
  124. A. Abudu, A. Takaori-Kondo, T. Izumi et al., “Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms,” Current Biology, vol. 16, no. 15, pp. 1565–1570, 2006. View at Publisher · View at Google Scholar · View at PubMed
  125. S. J. D. Neil, T. Zang, and P. D. Bieniasz, “Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu,” Nature, vol. 451, no. 7177, pp. 425–430, 2008. View at Publisher · View at Google Scholar · View at PubMed
  126. C. Goffinet, S. Schmidt, C. Kern, L. Oberbremer, and O. T. Keppler, “Endogenous CD317/tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses,” Journal of Virology, vol. 84, no. 21, pp. 11374–11384, 2010. View at Publisher · View at Google Scholar · View at PubMed
  127. D. T. Evans, R. Serra-Moreno, R. K. Singh, and J. C. Guatelli, “BST-2/tetherin: a new component of the innate immune response to enveloped viruses,” Trends in Microbiology, vol. 18, no. 9, pp. 388–396, 2010. View at Publisher · View at Google Scholar · View at PubMed
  128. S. P. Goff, “Host factors exploited by retroviruses,” Nature Reviews Microbiology, vol. 5, no. 4, pp. 253–263, 2007. View at Publisher · View at Google Scholar · View at PubMed